Our Services
Medical Information
Helpful Resources
Published on: 5/19/2026
When tissues don’t get enough oxygen, cells switch to anaerobic glycolysis and release lactate into the blood, so rising serum lactate serves as a sensitive marker of inadequate oxygen delivery in conditions like shock or sepsis. Monitoring lactate can detect early tissue hypoxia before overt organ failure.
There are several factors that influence lactate production and clearance which can impact your treatment plan, so see below for complete details to guide the next steps in your healthcare journey.
When your body's tissues don't get enough oxygen, cells switch from efficient, oxygen-dependent energy production to a less efficient, oxygen-independent process called anaerobic glycolysis. A byproduct of this switch is lactate. Clinically, rising serum lactate levels—often reported as lactic acidosis—serve as a sensitive marker that oxygen delivery to tissues is inadequate.
• Definition: Accumulation of lactate in the blood (typically >2 mmol/L) accompanied by a drop in blood pH.
• Type A vs. Type B:
– Type A: Due to tissue hypoxia (shock, sepsis, hemorrhage, heart failure)
– Type B: Due to metabolic problems (liver disease, certain toxins, medications)
• Cellular Response to Hypoxia
– Oxygen shortage slows the mitochondrial electron transport chain
– ATP generation drops; cells rely on glycolysis for energy
– Pyruvate accumulates and is converted to lactate
• Microcirculatory Impairment
– Low blood pressure or narrowed vessels reduce capillary flow
– Less oxygen reaches tissues, accelerating lactate build-up
• Enzyme Inhibition
– Hypoxia and acidosis inhibit pyruvate dehydrogenase, shunting more pyruvate to lactate
• Sepsis and Septic Shock
– Cytokine storm and vasodilation cause capillary leak and hypotension
– Elevated lactate (>4 mmol/L) correlates with higher mortality
• Cardiogenic Shock
– Heart can't pump enough blood → poor perfusion → lactic acidosis
• Hemorrhagic Shock
– Blood loss → low hemoglobin → insufficient oxygen delivery
• Severe Infections (including Hantavirus Pulmonary Syndrome)
– Capillary leak in lungs and other organs → hypoxia at the tissue level
– Lactic acidosis reflects severity and helps guide ICU care
Hantavirus Pulmonary Syndrome (HPS) is characterized by rapid onset of pulmonary edema, shock, and multi-organ dysfunction. Research shows:
• Early lactate elevation often precedes overt respiratory failure
• Persistent lactic acidosis (lactate >4 mmol/L) is linked to greater need for mechanical ventilation and worse outcomes
• Monitoring lactate clearance (percentage drop over 6 hours) can predict recovery versus progression to shock
• Normal: 0.5–1.9 mmol/L
• Mild elevation: 2.0–3.9 mmol/L
• Significant elevation: ≥4.0 mmol/L → urgent evaluation for shock or severe infection
• Lactate clearance:
– Goal: ≥10 % reduction in 6 hours in septic patients
– Slower clearance indicates ongoing tissue hypoxia or inadequate resuscitation
• Acid–base imbalance: Low pH impairs enzyme function and cardiac contractility
• Decreased vascular tone: Aggravates hypotension
• Altered oxygen delivery: Hemoglobin releases O₂ less effectively in acidemia
• Multi-organ dysfunction: Kidneys, heart, brain all vulnerable
• Persistent or rising lactate despite initial resuscitation
• Worsening shortness of breath, chest pain, confusion, or rapid heart rate
• Any signs of shock: cold clammy skin, very low blood pressure, reduced urine output
If you're experiencing concerning symptoms such as shortness of breath, rapid heart rate, or confusion, you can get immediate guidance through Ubie's Medically approved LLM Symptom Checker Chat Bot to help determine your next steps.
Always keep in mind: if you have life-threatening or rapidly worsening symptoms, call emergency services or go to the nearest emergency department immediately. And remember to speak to a doctor about any serious or persistent health issues—early recognition and treatment of lactic acidosis can be lifesaving.
(References)
* Vincent JL, De Backer D. Lactate as a biomarker and therapeutic target in critical care. Intensive Care Med. 2019 Jan;45(1):76-90. PMID: 30424508.
* Garcia-Alvarez M, Marik P, Bellomo R. Lactate in critically ill patients: from a marker of tissue hypoxia to a mediator of inflammation. Crit Care. 2021 May 2;25(1):159. PMID: 33924197.
* Bakker J, Kormann R. The role of lactate in the pathophysiology of critical illness. Curr Opin Crit Care. 2020 Jun;26(3):315-322. PMID: 32488344.
* De Jong A, Verdier D, Verzilli D, Jung B, Claret PG, Jaber S. Lactate: friend or foe? An update for the intensivist. J Clin Monit Comput. 2018 Oct;32(5):789-798. PMID: 29033878.
* Jahan I, Koga S, Fujiwara H. Physiology of lactate metabolism: an update for the clinician. Br J Anaesth. 2015 Jan;114(1):12-24. PMID: 25501869.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.